← Open Payments lookup

JOHN KEMP: Open Payments

NPI 1053967463 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,895 in 114 payments from 13 companies in 2025. Trend: 2023 $1,759 · 2024 $2,076 · 2025 $2,895

Food & beverage: $2,883Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)43$619
Neurocrine BioSciences, Inc.23$530
Vanda Pharmaceuticals Inc.11$324
ABBVIE INC.6$295
Janssen Pharmaceuticals, Inc3$272
Axsome Therapeutics, Inc.2$220
E.R. Squibb & Sons, L.L.C.8$154
Teva Pharmaceuticals USA, Inc.3$143
Alkermes, Inc.9$138
Otsuka America Pharmaceutical, Inc.2$93

Products named: CAPLYTA, INGREZZA, FANAPT, VRAYLAR, INVEGA SUSTENNA, Auvelity, COBENFY, UZEDY.

Industry payments across CT — which companies pay providers there.